Report Overview

2023

Base Year

2018-2023

Historical Year

2024-2032

Forecast Year

Leading Players in the Middle East and Africa Generic Injectables Market

The key features of the market report include patent analysis, grants analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:

 

Pfizer Inc.

Pfizer has a strong presence in the sterile injectables industry, with a range of offerings in generic and branded products. To expand its market presence in the generic injectables sector, it acquired a leading manufacturer of injectable drugs and infusion technologies, Hospira, in 2015.

 

Baxter

A global leader in generic injectables, Baxter International Inc., is actively engaged in strategic mergers and acquisition activities to bolster the development of generic injectables in various therapeutic categories.

 

Hikma Pharmaceuticals PLC

This British multinational pharmaceutical company is known for its non-branded generic and in-licensed products. It is a leading supplier of injectable pharmaceuticals in the Middle East and North African countries and is focusing on expanding local manufacturing operations in the region.

 

Dr. Reddy’s Laboratories Ltd.

Dr. Reddy's Laboratories, an Indian multinational pharmaceutical company, is a prominent player in the market. It specializes in developing generic formulations, including injectables, tablets, capsules, and topical creams across the major therapeutic areas.

 

Other players in the market include Viatris Inc., and Sanofi, among others.

 

Middle East and Africa Generic Injectables Market Report Snapshots

Middle East and Africa Generic Injectables Market Size

Middle East and Africa Generic Injectables Market Analysis

Middle East and Africa Generic Injectables Companies

 

*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*

Looking for specific insights?

Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!

Key Questions Answered in the Report

The market attained a value of about USD 0.9 billion in 2023 driven by the growth in local generic manufacturing capabilities in the region.

The market is anticipated to grow at a CAGR of 7.80% during the forecast period of 2024-2032, likely to reach a market value of USD 1.9 billion by 2032. 

The rising investment in healthcare infrastructure and the growing healthcare needs are fuelling the demand for the market.

One of the significant trends in the market is the increase in public-private partnerships to accelerate the availability of affordable generic injectables in low-income countries. In July 2022, GSK plc announced one such strategic partnership with the Medicines Patent Pool to accelerate access to new HIV therapies in poor countries, with the introduction of its generic injectables expected by 2026. 

Based on the product type, the market is segmented into large molecule injectables and small molecule injectables.

Container types available in the market include vials, premix, prefilled syringes, and ampoules, among others.

Major applications include oncology, cardiovascular, CNS, infectious diseases, and autoimmune disorders, among others.

The market breakup by route of administration includes intravenous, intramuscular, and subcutaneous, among others.

Distribution channels of the market are hospitals and retail pharmacies, among others.

The market segmentation by countries includes Saudi Arabia, the United Arab Emirates, Nigeria, and South Africa, among others.  

The key players in the market are Pfizer Inc., Baxter, Hikma Pharmaceuticals PLC, Dr. Reddy’s Laboratories Ltd., Viatris Inc., and Sanofi.

Purchase Full Report

Datasheet

 

USD 2,639

USD 2,399

tax inclusive*

  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

One User

USD 4,399

USD 3,999

tax inclusive*

  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Five User License

Five Users

USD 5,829

USD 5,299

tax inclusive*

  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

Unlimited Users

USD 6,929

USD 6,299

tax inclusive*

  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

How To Order

Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.

Select License Type

Choose the right license for your needs and access rights.

Click on ‘Buy Now’

Add the report to your cart with one click and proceed to register.

Select Mode of Payment

Choose a payment option for a secure checkout. You will be redirected accordingly.

Strategic Solutions for Informed Decision-Making

Connect For More Information

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.

Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.

We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.

Back to top

We’re here to help answer any questions about our products and services.

Contact us

Our Offices


Australia

63 Fiona Drive, Tamworth, NSW

+61 448 06 17 27

India

C130 Sector 2 Noida, Uttar Pradesh 201301

+91-858-608-1494

Philippines

40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.

+63 287899028, +63 967 048 3306

United Kingdom

6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London

+44-753-713-2163

United States (Head Office)

30 North Gould Street, Sheridan, WY 82801

+1-415-325-5166

Vietnam

193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City

+84865399124

$getforecastarray = array(); if (isset($ismapshow)) { $forecast_period_start = isset($forecast_period_start) ? $forecast_period_start : ''; if ($forecast_period_start != "") { $yearInc = 1; for ($startfrom = $forecast_period_start; $startfrom <= $forecast_period_end; $startfrom++) { $calculatFercastYear = calculateFutureValue(($getReportDetail['base_value'] > 0) ? $getReportDetail['base_value'] : 100, $getReportDetail['cagr'], $yearInc); $getforecastarray[] = array('years' => "$startfrom", 'value' => $calculatFercastYear); $yearInc++; } } } $getforecastarrayJson = json_encode($getforecastarray); ?>